Please ensure Javascript is enabled for purposes of website accessibility
Alex Carchidi

Alex Carchidi

TMFacarchidi

Alex began writing for the Fool in early 2020 and follows companies in the healthcare sector. Formerly a researcher in the biotech industry, he leverages his science background in his work as a writer and entrepreneur. His interests include exploring his hometown of Boston, traveling in Latin America, and value investing.

Recent articles

nurse in ppe prepares to swab man

3 Things About Abbott Laboratories That Smart Investors Know

It isn't a stock for the impatient.


surgeon works alongside surgical robot

Here's What Investors Should Look for in Intuitive Surgical's Earnings Report

The biggest questions relate to how it's faring amid the omicron variant's disruption.


doctor loads syringe with vaccine

2 Top Healthcare Stocks Ready for a Bull Run

Their performance in 2022 might be even better for them than 2021 was.


cannabis farmer in greenhouse

Could Innovative Industrial Properties Stock Help You Retire a Millionaire?

Yes, if you're patient.


healthcare worker swabs man

Will Abbott Laboratories Be a Trillion-Dollar Stock by 2035?

Probably not, but it's possible.

GettyImages-1215331788

Is Biogen a Buy After the Latest Aduhelm Disaster?

Only if you're (really) brave.


man gets covid test

Will Demand for Rapid COVID-19 Tests Help Abbott Laboratories Beat the Market in 2022?

It didn't work out that way in 2021.


cannabis worker compares plants

HEXO Stock: Bull vs. Bear

It might be able to outgrow its profitability issues, but the jury's still out.


worker holds coronavirus vaccine syringe

Better Buy: Novavax vs. Moderna

Both of these coronavirus vaccine innovators have plenty of upside in 2022.


Healthcare coworkers using digital tablet at hospital

3 Healthcare Stocks to Buy and Hold for the Next 10 Years

Their products are indispensible, and their continued growth is nearly guaranteed.

vet holds dog

Buy and Hold This Unstoppable Growth Stock for the Next Decade

When it comes to raking in recurring revenue, this company is a king.


farmer inspects marijuana plant in greenhouse

Sundial Growers Stock: Bull vs. Bear

This stock isn't a slam dunk, but it could be ripe for a turnaround.


GettyImages-493302504

2 Under-the-Radar Biotech Picks to Buy For The Long Haul

These quiet biotechs are tightly focused and practically alone in their markets.


three doctors and three nurses discuss a readout at a table

Bristol Myers Squibb Stock: Bull vs. Bear

The next few years might be hard for shareholders expecting outperformance.


pharmacist stands in pharmacy

Better Buy: Viatris vs. AbbVie

Both face headwinds -- and future opportunities.

surgeon controls robotic surgical unit

Could Intuitive Surgical Stock Hit $500 in 2022?

If it makes a major new announcement, it just might be possible.


GettyImages-1201024604

3 Things About Novavax That Smart Investors Know

2022 will be a watershed year for the company in more ways than one.


doctor loads syringe with vaccine

What Are the Best Vaccine Stocks to Own in 2022?

The most-advanced vaccine developers will continue to lead the pack.


GettyImages-1251612669

This Wildly Undervalued Cannabis Stock Could Go Parabolic in 2022

This profitable growth stock is primed for success, and it's trading cheaply, too.


scientist works at lab bench

2 Top Healthcare Stocks Ready for a Bull Run in 2022

They've strongly outperformed the market in the past, and they could easily do it again.